Low–Molecular Weight Heparin for Pancreatic Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
J. Clin. Oncol 2015 May 18;[EPub Ahead of Print], U Pelzer, B Opitz, G Deutschinoff, M Stauch, PC Reitzig, S Hahnfeld, L Müller, M Grunewald, JM Stieler, M Sinn, T Denecke, S Bischoff, H Oettle, B Dörken, H RiessFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.